“verastem” Archives

in
Entry Author Date Location
Verastem Bucks the Trend, Raises $55M in IPO 01/26/12 Boston
Verastem Lands $20,102,609 New Funding Round 11/11/11 Boston
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
This Week’s Xconomy Report on WGBH: Zuckerberg’s Change of Heart, IDing Adults Online, Vocal Cord Repair, and Verastem IPO 11/04/11 Boston
Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News 11/04/11 Boston
VC Investment in MA Companies Falls Back to Earth (from $1B to $505M): Top 10 Q3 Deals 10/24/11 Boston
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Verastem, Rooted at MIT, Raises $32 Million and Adds ATV and Astellas to Slate of Investors 07/14/11 Boston
Verastem Obtains $32,000,000 Series B Financing Round 07/14/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Termeer Joins Verastem Board 06/13/11 Boston
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model 06/08/11 New York
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund 01/06/11 Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News 01/05/11 Boston
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells 11/16/10 Boston
Verastem Secures $16,000,000 Series A Round 11/16/10 Boston
Page 2 of 2 « previous page